Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health, Inc. provides home and alternate-site infusion services for patients with acute and chronic conditions across the United States. The company operates in infusion services and reports developments tied to clinical service delivery, national provider relationships, and the economics of its care model.
Recurring news for OPCH includes quarterly and full-year financial results, guidance updates, operating cash flow, share repurchase activity, credit facility changes, and presentations at health care investor conferences. Company updates also address capital allocation and management commentary related to revenue growth and profitability in home and alternate-site infusion care.
Option Care Health (NASDAQ:OPCH) has been ranked No. 15 on the World’s Most Impactful Companies 2026 list by TIME and Statista. The ranking uses The Upright Project’s science-based Net Impact Model to assess net-positive impact across Society, Knowledge, Health, and Environment.
This third-party recognition highlights Option Care Health’s measured impact and its role as the largest independent provider of home and alternate site infusion services in the U.S., with over 8,000 team members serving patients in all 50 states.
Option Care Health (Nasdaq: OPCH) will participate in the Bank of America Health Care Conference in Las Vegas on May 12, 2026, including a fireside chat at 10:40am PT / 1:40pm ET. The event will be webcast live at the company's investor website.
The release reiterates Option Care Health's role as the nation's largest independent provider of home and alternate site infusion services, with over 8,000 team members including more than 5,000 clinicians operating in all 50 states.
Option Care Health (Nasdaq: OPCH) reported Q1 2026 results: net revenue $1,350.7M (+1.3% YoY), GAAP net income $45.3M, GAAP diluted EPS $0.29, Adjusted EBITDA $104.8M (down 6.3%), and cash used in operations $12.1M. The company repurchased $17.5M of stock and expanded its revolving credit facility to $850M. Updated full‑year 2026 guidance: revenue $5.675B–$5.775B, adjusted diluted EPS $1.82–$1.92, adjusted EBITDA $480M–$505M, and cash from operations of at least $320M.
Option Care Health (NASDAQ: OPCH) will release first-quarter 2026 results for the period ended March 31, 2026 on Thursday, April 30, 2026 before the market opens. Management will host a conference call at 8:30 a.m. ET the same day with a live audio webcast and an on-demand replay available for about 90 days.
Option Care Health (Nasdaq: OPCH) reported fourth-quarter and full-year 2025 results. Full-year net revenue rose 13.0% to $5,649.5 million and adjusted EBITDA was $471.3 million. GAAP net income was $207.6 million. The company repurchased $307 million of stock in 2025 and provided 2026 guidance.
Full-year 2026 guidance: net revenue $5.8B–$6.0B, adjusted diluted EPS $1.82–$1.92, and adjusted EBITDA $480M–$505M.
Option Care Health (Nasdaq: OPCH) will participate in the 46th Annual TD Cowen Healthcare Conference in Boston on Tuesday, March 3, 2026, including a fireside chat at 1:10 PM ET. The company will webcast the presentation at its investor site.
Option Care Health is described as the nation’s largest independent provider of home and alternate site infusion services, with over 8,000 team members and more than 5,000 clinicians serving all 50 states.
Option Care Health (NASDAQ: OPCH) will release its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 before the market opens. Management will host a conference call to review the results at 8:30 a.m. ET the same day.
Participants can pre-register for the call via the provided registration link and listen via a live audio webcast at investors.optioncarehealth.com. A replay will be available on the same webcast link for approximately 90 days after the call.
Option Care Health (Nasdaq: OPCH) reported preliminary unaudited results for Q4 and full year 2025 and provided preliminary guidance for full year 2026. Q4 2025 net revenue is expected to be $1.46–1.47B, GAAP diluted EPS $0.37–0.39, adjusted diluted EPS $0.46–0.49, and adjusted EBITDA $123.7–127.7M. Full year 2025 net revenue is expected at $5.645–5.655B, GAAP diluted EPS $1.27–1.29, adjusted diluted EPS $1.72–1.76, adjusted EBITDA $469–473M, and operating cash flow below $320M. 2026 guidance calls for net revenue $5.8–6.0B, adjusted diluted EPS $1.82–1.92, and adjusted EBITDA $480–505M. The board expanded the share repurchase authorization to $1.0B (added $500M); ~$307M was repurchased in 2025.
Option Care Health (Nasdaq: OPCH) will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 with a presentation at 10:30am PT.
The company said the webcast and presentation materials will be available at https://investors.optioncarehealth.com. Option Care Health describes itself as the nation’s largest independent provider of home and alternate site infusion services, with over 8,000 team members including more than 5,000 clinicians serving all 50 states.
Option Care Health (Nasdaq: OPCH) will participate in four investor conferences in November–December 2025, presenting corporate updates and fielding investor questions.
Schedule: UBS Global Healthcare in Palm Beach on Nov 11, 2025 at 3:30pm ET; Jefferies London Healthcare in London on Nov 19, 2025 at 3:30pm GMT; Bank of America Leveraged Finance in Boca Raton on Dec 2, 2025 at 10:50am ET; and Bank of America Home Care (virtual) on Dec 8, 2025 at 10:50am ET.
Webcasts and presentation materials, if applicable, will be available at https://investors.optioncarehealth.com. The company states it employs over 8,000 team members including more than 5,000 clinicians and provides home and alternate site infusion services across all 50 states.